ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
2.290
-0.010 (-0.43%)
Dec 5, 2025, 4:00 PM EST - Market closed
ImmunityBio Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for ImmunityBio stock ranges from a low of $5.00 to a high of $24. The average analyst price target of $9.83 forecasts a 329.26% increase in the stock price over the next year.
Price Target: $9.83 (+329.26%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ImmunityBio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $24 | Strong Buy | Maintains | $24 | +948.03% | Nov 13, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $24 | Strong Buy | Maintains | $24 | +948.03% | Nov 5, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $8 | Strong Buy | Reiterates | $8 | +249.34% | Sep 10, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $24 | Strong Buy | Maintains | $24 | +948.03% | Sep 8, 2025 |
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $24 | Strong Buy | Maintains | $24 | +948.03% | Aug 26, 2025 |
Financial Forecast
Revenue This Year
113.12M
from 14.75M
Increased by 667.18%
Revenue Next Year
213.03M
from 113.12M
Increased by 88.32%
EPS This Year
-0.46
from -0.62
EPS Next Year
-0.34
from -0.46
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 121.3M | 258.0M | ||||
| Avg | 113.1M | 213.0M | ||||
| Low | 106.6M | 152.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 722.5% | 128.1% | ||||
| Avg | 667.2% | 88.3% | ||||
| Low | 622.6% | 35.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.37 | -0.25 | ||||
| Avg | -0.46 | -0.34 | ||||
| Low | -0.63 | -0.47 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.